Methotrexate monotherapy for unilateral moderately active thyroid-related eye disease.
Ayman G ElnahryJoseph H TalbetGehad A ElnahryPublished in: Clinical case reports (2021)
A type 1 diabetic patient with unilateral active thyroid-related eye disease was intolerant to systemic steroid therapy due to uncontrollable blood sugar levels. She was treated with low-dose methotrexate monotherapy, which resulted in a marked improvement of her condition with no adverse events.